
MEA Acute Respiratory Distress Syndrome (ARDS) Treatment Market
Description
MEA Acute Respiratory Distress Syndrome (ARDS) Treatment Market
The Middle East and Africa Acute Respiratory Distress Syndrome (ARDS) treatment market is expected to reach USD 302,177.14 thousand by 2030, from USD 164,931.47 thousand in 2022, growing at the CAGR of 8.3% in the forecast period of 2023 to 2030.
Market Segmentation
Middle East and Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type (Mechanical Ventilation, Corticosteroids, Antiviral Medication, Extracorporeal Membrane Oxygenation (ECMO), Tocilizumab, and Others), Cause ( Sepsis, Inhalation of Harmful Substances, Severe Pneumonia, and Others), Route of Administration (Parenteral, Oral, and Others), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Kuwait, and rest of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Middle East and Africa Acute Respiratory Distress Syndrome (ARDS) Treatment Market Dynamics
Driver
• Increasing prevalence and incidence of acute lung injury in the market
Restraint
• High cost of device and treatment
Opportunity
• Strategic initiatives joined with new product launches by market players
Market Players
Some of the major market players operating in the Middle East and Africa Acute Respiratory Distress Syndrome (ARDS) market are listed below:
• Gilead Sciences, Inc.
• Terumo Medical Corporation
• Getinge AB.
• LivaNova PLC
• Medtronic
• ResMed
• Fisher & Paykel Healthcare Limited.
• Drägerwerk AG & Co. KGaA
• NIPRO
• Fresenius SE & Co. KGaA
• Hamilton Medical
• Pfizer Inc.
• WEINMANN Emergency Medical Technology GmbH + Co. KG
• EUROSETS
• Armstrong Medical
• nice Neotech Medical Systems Pvt. Ltd.
• Besmed Health Business Corp.
Table of Contents
165 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 4.3 Insurance Reimbursement
- 4.3.1 Center For Medicare Services (Cms)–elso (Extracorporeal Life Support Organization)
- 4.3.2 Health Resources And Services Administration
- 4.3.3 Abbott Coding Guide For Ecmo
- 4.3.4 Central Government Health Scheme (Cghs)
- 4.3.5 Cern Health Insurance Scheme
- 4.3.6 American Society Of Clinical Oncology (Asco) – (Medicare & Medicaid)
- 4.3.7 American Hospital Association
- 4.4 Pipeline Analysis
- 4.5 Pricing Analysis
- 5 Market Overview
- 5.1 Drivers
- 5.1.1 Increasing Prevalence And Incidence Of Acute Lung Injury
- 5.1.2 Wide Range Of Risk Factors For Ards Treatment
- 5.1.3 Rising Rate Of Air Pollution And Unhealthy Lifestyle
- 5.1.4 Increasing Accident Rates And Trauma Causing Ards
- 5.2 Restraints
- 5.2.1 Complications Associated With The Treatment
- 5.2.2 High Cost Of Devices And Treatment
- 5.3 Opportunities
- 5.3.1 Rising Healthcare Expenditure To Improve Treatment Facilities
- 5.3.2 Strategic Initiatives Joined With New Product Launch By Market Players
- 5.3.3 Improving Awareness Regarding Ard Syndrome
- 5.4 Challenges
- 5.4.1 Stringent Rules & Regulations
- 5.4.2 Multiple Challenges Faced By Icu Staff
- 6 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type
- 6.1 Overview
- 6.2 Mechanical Ventilation
- 6.2.1 High-flow Nasal O2
- 6.2.2 Bi-level Positive Airway Pressure
- 6.2.3 Continuous Positive Airway Pressure
- 6.2.4 Prone Position Ventilation
- 6.2.5 Others
- 6.3 Corticosteroids
- 6.3.1 Methylprednisolone
- 6.3.2 Dexamethasone
- 6.3.3 Others
- 6.4 Antiviral Medication
- 6.4.1 Ribavirin
- 6.4.2 Oseltamivir
- 6.4.3 Others
- 6.5 Extracorporeal Membrane Oxygenation (Ecmo)
- 6.6 Tocilizumab
- 6.7 Others
- 7 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause
- 7.1 Overview
- 7.2 Sepsis
- 7.3 Inhalation Of Harmful Substances
- 7.4 Severe Pneumonia
- 7.5 Others
- 8 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration
- 8.1 Overview
- 8.2 Parenteral
- 8.2.1 Intravenous
- 8.2.2 Intramuscular
- 8.3 Oral
- 8.4 Others
- 9 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User
- 9.1 Overview
- 9.2 Hospitals
- 9.3 Specialty Clinics
- 9.4 Home Healthcare
- 9.5 Others
- 10 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel
- 10.1 Overview
- 10.2 Direct Tender
- 10.3 Hospital Pharmacy
- 10.4 Retail Pharmacy
- 10.5 Online Pharmacy
- 11 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region
- 11.1 Middle East And Africa
- 11.1.1 South Africa
- 11.1.2 Saudi Arabia
- 11.1.3 U.A.E
- 11.1.4 Israel
- 11.1.5 Egypt
- 11.1.6 Kuwait
- 11.1.7 Rest Of Middle East And Africa
- 12 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, Company Landscape
- 12.1 Company Share Analysis: Middle East And Africa
- 13 Swot Analysis
- 14 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment, Cps
- 14.1 Gilead Sciences Inc.
- 14.1.1 Company Snapshot
- 14.1.2 Revenue Analysis
- 14.1.3 Company Share Analysis
- 14.1.4 Product Portfolio
- 14.1.5 Recent Development
- 14.2 Terumo Corporation
- 14.2.1 Company Snapshot
- 14.2.2 Revenue Analysis
- 14.2.3 Company Share Analysis
- 14.2.4 Product Portfolio
- 14.2.5 Recent Development
- 14.3 Getinge
- 14.3.1 Company Snapshot
- 14.3.2 Revenue Analysis
- 14.3.3 Company Share Analysis
- 14.3.4 Product Portfolio
- 14.3.5 Recent Development
- 14.4 Livanova Plc
- 14.4.1 Company Snapshot
- 14.4.2 Revenue Analysis
- 14.4.3 Company Share Analysis
- 14.4.4 Product Portfolio
- 14.4.5 Recent Developments
- 14.5 Medtronic
- 14.5.1 Company Snapshot
- 14.5.2 Revenue Analysis
- 14.5.3 Company Share Analysis
- 14.5.4 Product Portfolio
- 14.5.5 Recent Developments
- 14.6 Armstrong Medical
- 14.6.1 Company Snapshot
- 14.6.2 Product Portfolio
- 14.6.3 Recent Development
- 14.7 Besmed Health Business Corp.
- 14.7.1 Company Snapshot
- 14.7.2 Product Portfolio
- 14.7.3 Recent Developments
- 14.8 Drägerwerk Ag & Co. Kgaa
- 14.8.1 Company Snapshot
- 14.8.2 Revenue Analysis
- 14.8.3 Product Portfolio
- 14.8.4 Recent Developments
- 14.9 Eurosets
- 14.9.1 Company Snapshot
- 14.9.2 Product Portfolio
- 14.9.3 Recent Development
- 14.10 Fisher & Paykel Healthcare Limited
- 14.10.1 Company Snapshot
- 14.10.2 Revenue Analysis
- 14.10.3 Product Portfolio
- 14.10.4 Recent Developments
- 14.11 Fresenius Se & Co. Kgaa.
- 14.11.1 Company Snapshot
- 14.11.2 Revenue Analysis
- 14.11.3 Product Portfolio
- 14.11.4 Recent Development
- 14.12 Hamilton Medical
- 14.12.1 Company Snapshot
- 14.12.2 Product Portfolio
- 14.12.3 Recent Development
- 14.13 Nice Neotech Medical Systems Pvt.Ltd.
- 14.13.1 Company Snapshot
- 14.13.2 Product Portfolio
- 14.13.3 Recent Development
- 14.14 Nipro
- 14.14.1 Company Snapshot
- 14.14.2 Revenue Analysis
- 14.14.3 Product Portfolio
- 14.14.4 Recent Development
- 14.15 Pfizer Inc.
- 14.15.1 Company Snapshot
- 14.15.2 Revenue Analysis
- 14.15.3 Product Portfolio
- 14.15.4 Recent Development
- 14.16 Resmed
- 14.16.1 Company Snapshot
- 14.16.2 Revenue Analysis
- 14.16.3 Product Portfolio
- 14.16.4 Recent Development
- 14.17 Weinmann Emergency Medical Technology Gmbh + Co. Kg
- 14.17.1 Company Snapshot
- 14.17.2 Product Portfolio
- 14.17.3 Recent Development
- 15 Questionnaire
- 16 Related Reports
- List Of Tables
- Table 1 List Of Prices For Approved Drugs For Acute Respiratory Distress Syndrome (Ards) Treatment
- Table 2 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 3 Middle East And Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 4 Middle East And Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 5 Middle East And Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 6 Middle East And Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 7 Middle East And Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 8 Middle East And Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 9 Middle East And Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 10 Middle East And Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 11 Middle East And Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 12 Middle East And Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 13 Middle East And Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 14 Middle East And Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 15 Middle East And Africa Extracorporeal Membrane Oxygenation (Ecmo) In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 16 Middle East And Africa Tocilizumab In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 17 Middle East And Africa Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 18 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 19 Middle East And Africa Sepsis In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 20 Middle East And Africa Inhalation Of Harmful Substances In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 21 Middle East And Africa Severe Pneumonia In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 22 Middle East And Africa Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 23 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 24 Middle East And Africa Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 25 Middle East And Africa Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 26 Middle East And Africa Oral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 27 Middle East And Africa Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 28 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 29 Middle East And Africa Hospitals In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 30 Middle East And Africa Specialty Clinics In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 31 Middle East And Africa Home Healthcare In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 32 Middle East And Africa Others In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 33 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 34 Middle East And Africa Direct Tender In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 35 Middle East And Africa Hospital Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 36 Middle East And Africa Retail Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 37 Middle East And Africa Online Pharmacy In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Region, 2021-2030 (Usd Thousand)
- Table 38 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Country, 2021-2030 (Usd Thousand)
- Table 39 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 40 Middle East And Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 41 Middle East And Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 42 Middle East And Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 43 Middle East And Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 44 Middle East And Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 45 Middle East And Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 46 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 47 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 48 Middle East And Africa Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 49 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 50 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 51 South Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 52 South Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 53 South Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 54 South Africa Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 55 South Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 56 South Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 57 South Africa Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 58 South Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 59 South Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 60 South Africa Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 61 South Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 62 South Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 63 South Africa Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 64 South Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 65 South Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 66 Saudi Arabia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 67 Saudi Arabia Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 68 Saudi Arabia Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 69 Saudi Arabia Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 70 Saudi Arabia Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 71 Saudi Arabia Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 72 Saudi Arabia Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 73 Saudi Arabia Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 74 Saudi Arabia Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 75 Saudi Arabia Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 76 Saudi Arabia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 77 Saudi Arabia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 78 Saudi Arabia Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 79 Saudi Arabia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 80 Saudi Arabia Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 81 U.A.E Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 82 U.A.E Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 83 U.A.E Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 84 U.A.E Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 85 U.A.E Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 86 U.A.E Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 87 U.A.E Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 88 U.A.E Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 89 U.A.E Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 90 U.A.E Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 91 U.A.E Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 92 U.A.E Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 93 U.A.E Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 94 U.A.E Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 95 U.A.E Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 96 Israel Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 97 Israel Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 98 Israel Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 99 Israel Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 100 Israel Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 101 Israel Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 102 Israel Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 103 Israel Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 104 Israel Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 105 Israel Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 106 Israel Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 107 Israel Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 108 Israel Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 109 Israel Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 110 Israel Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 111 Egypt Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 112 Egypt Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 113 Egypt Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 114 Egypt Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 115 Egypt Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 116 Egypt Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 117 Egypt Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 118 Egypt Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 119 Egypt Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 120 Egypt Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 121 Egypt Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 122 Egypt Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 123 Egypt Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 124 Egypt Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 125 Egypt Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 126 Kuwait Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 127 Kuwait Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 128 Kuwait Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 129 Kuwait Mechanical Ventilation In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 130 Kuwait Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 131 Kuwait Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 132 Kuwait Corticosteroids In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 133 Kuwait Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- Table 134 Kuwait Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Volume)
- Table 135 Kuwait Antiviral Medication In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Asp)
- Table 136 Kuwait Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Cause, 2021-2030 (Usd Thousand)
- Table 137 Kuwait Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 138 Kuwait Parenteral In Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand)
- Table 139 Kuwait Acute Respiratory Distress Syndrome (Ards) Treatment Market, By End User, 2021-2030 (Usd Thousand)
- Table 140 Kuwait Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
- Table 141 Rest Of Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market, By Type, 2021-2030 (Usd Thousand)
- List Of Figures
- Figure 1 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Segmentation
- Figure 2 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Data Triangulation
- Figure 3 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Droc Analysis
- Figure 4 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Middle East And Africa Vs Regional Market Analysis
- Figure 5 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Company Research Analysis
- Figure 6 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Interview Demographics
- Figure 7 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Dbmr Market Position Grid
- Figure 8 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Market End User Coverage Grid
- Figure 9 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Vendor Share Analysis
- Figure 10 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market: Segmentation
- Figure 11 Increasing Prevalence And Incidence Of Acute Lung Injury Are Expected To Drive The Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market In The Forecast Period Of 2022 To 2030
- Figure 12 Mechanical Ventilation Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Market In 2023 & 2030
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Middle East And Africa Duchenne Muscular Dystrophy Treatment Market
- Figure 14 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, 2022
- Figure 15 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, 2023-2030 (Usd Thousand)
- Figure 16 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, Cagr (2023-2030)
- Figure 17 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Type, Lifeline Curve
- Figure 18 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, 2022
- Figure 19 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, 2023-2030 (Usd Thousand)
- Figure 20 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, Cagr (2023-2030)
- Figure 21 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Cause, Lifeline Curve
- Figure 22 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, 2022
- Figure 23 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, 2023-2030 (Usd Thousand)
- Figure 24 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, Cagr (2023-2030)
- Figure 25 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Route Of Administration, Lifeline Curve
- Figure 26 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, 2022
- Figure 27 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, 2023-2030 (Usd Thousand)
- Figure 28 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, Cagr (2023-2030)
- Figure 29 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By End User, Lifeline Curve
- Figure 30 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, 2022
- Figure 31 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand)
- Figure 32 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, Cagr (2023-2030)
- Figure 33 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: By Distribution Channel, Lifeline Curve
- Figure 34 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: Snapshot (2022)
- Figure 35 Middle East And Africa Acute Respiratory Distress Syndrome (Ards) Treatment Market: Company Share 2022 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.